Estados Unidos · Bolsa y Finanzas · MarketWatch

Bristol Myers Squibb Says FDA Approves Heart Disease Treatment Camzyos for Pediatric Patients

Publicado por MarketWatch · Estados Unidos hace 13 h

Bristol Myers Squibb said the Food and Drug Administration approved Camzyos to treat symptomatic obstructive hypertrophic cardiomyopathy in adults and pediatric patients weighing…

Leer el artículo completo en MarketWatch Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketwatch.com)

Bristol Myers Squibb Says FDA Approves Heart Disease Treatment Camzyos for Pediatric Patients

También te puede interesar

South Korean President Lee pushes back on Alaska LNG project after Trump touts Seoul's participation

MetaMask exits Lido validators as it investigates security incident

Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges

Read the letter Trump is sending along with $500 checks to nearly 1 million Americans for ACA 'refunds'

Iran’s Disappearing Oil Is Becoming Everyone’s Problem

Google releases Gemini 4 Argon, called its most powerful model yet

Bristol Myers Squibb Says FDA Approves Heart Disease Treatment Camzyos for Pediatric Patients

Compartir

También te puede interesar

South Korean President Lee pushes back on Alaska LNG project after Trump touts Seoul's participation

MetaMask exits Lido validators as it investigates security incident

Investors thought they were buying pre-IPO OpenAI and SpaceX shares. Their cash went to strip clubs, Bloomingdale’s, and shopping on Amazon, SEC alleges

Read the letter Trump is sending along with $500 checks to nearly 1 million Americans for ACA 'refunds'

Iran’s Disappearing Oil Is Becoming Everyone’s Problem

Google releases Gemini 4 Argon, called its most powerful model yet